My current research interests involve sports pharmacy and the use of performance enhancing
drugs. I was the principle investigator of the Anabolic 500, a study which recruited
over 500 anabolic steroid users and analyzed motivations for use, exercise patterns,
psychiatric traits, and illicit drug use. I am currently heading a new study titled, CASTRO,
where we aim to determine whether injection practices and other risky lifestyle behaviors
may be an avenue for spread of infectious disease.

I am also involved in research on infant teething, diabetes/cardiovascular outcomes, educational/teaching methodology, academic dishonesty, and faculty work-life balance.

Jalloh MA, Doroudgar S, Ip EJ. What is the impact of the 2017 Cochrane Systematic Review and Meta-Analysis that
evaluated the use of PCSK9 Inhibitors for lowering cardiovascular disease and mortality?
Expert Opinion on Pharmacotherapy. [in press]